Elevated serum neurofilament light chain (sNfL) levels in patients with multiple sclerosis, Alzheimer’s disease, Parkinson’s and Huntington’s diseases, motor neuron diseases, cerebrovascular accidents, hereditary peripheral neuropathies, and impairments associated with traumatic brain injury (16–21). Here, NEFL is linked to Alzheimer disease.